Performance of the QIAstat-Dx Gastrointestinal Panel for Diagnosing Infectious Gastroenteritis

2020/01/07 by Stefan A. Boers, Cas J. A. Peters, Els Wessels +2
Agricultural and Biological Sciences · Medicine · #Acute gastroenteritis #Biology #Clostridium difficile and Clostridium perfringens research #Diagnostic test #Diarrhea #Intensive care medicine #Internal medicine #Isolation (microbiology) #Medicine #Microbiology #Pediatrics #Salmonella and Campylobacter epidemiology #Viral gastroenteritis research and epidemiology #Virology

paper · doi:10.1128/jcm.01737-19

openalex publication_date 2020/01/07 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/01

Abstract

values that could help with the interpretation of results. However, compared to LDTs, the GIP assay is limited by flexibility and high-throughput testing. In conclusion, the GIP assay offers an easy, sample-to-answer workflow with a rapid detection of the most common enteropathogens and therefore has the potential to direct appropriate therapy and infection control precautions.

Related

• Antimicrobial changes made for suspected infectious diarrhea after positive gastrointestinal pathogen panel result
• Repeat multiplex PCR gastrointestinal panel testing within 14 days yields minimal additional diagnostic information: a multicenter cohort study
• Overuse of a molecular infectious diarrhea panel in acute care: an opportunity for diagnostic stewardship
• Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Bacterial Gastroenteritis
• Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment